Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

1062 result(s) found, displaying 676 to 700

  • AusPAR: Canakinumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Canakinumab

  • AusPAR: Enzalutamide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Enzalutamide

  • AusPAR: Fenofibrate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Fenofibrate

  • AusPAR: Vedolizumab (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Vedolizumab (rch)

  • AusPAR: Ocriplasmin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ocriplasmin

  • AusPAR: Bevacizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Bevacizumab

  • AusPAR: Simeprevir (as sodium)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Simeprevir (as sodium)

  • AusPAR: Pomalidomide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Pomalidomide

  • AusPAR: Trastuzumab emtansine

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Trastuzumab emstansine

  • AusPAR: Eftrenonacog alfa

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Eftrenanocog alfa

  • AusPAR: Taliglucerase alfa rpc

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Taliglucerase alfa rpc

  • AusPAR: Aclidinium bromide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Aclidinium bromide

  • AusPAR: Rituximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rituximab

  • AusPAR: Obinutuzumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Obinutuzumab

  • AusPAR: Certolizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Certolizumab

  • AusPAR: Sofosbuvir

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Sofusbuvir

  • AusPAR: Sorafenib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Sorafenib

Help us improve the Therapeutic Goods Administration site